P18-12 LB. Phase I clinical trial with a new recombinant MVA-BN(®)-multiantigen vaccine: high responder rate and considerable breadth of immunological response

Detalles Bibliográficos
Autores principales: Overton, T, Schmidt, D, Hain, J, Virgin, G, Steigerwald, R, Dirmeier, U, Jordan, E, Meyer, T, Young, P, Ludvigsen, A, Nichols, R, Chaplin, P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767928/
http://dx.doi.org/10.1186/1742-4690-6-S3-P411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767928/
http://dx.doi.org/10.1186/1742-4690-6-S3-P411

Ejemplares similares